Biomarin Pharmaceutical (bmrn 1.25 05/15/27)
13F holders, Q2 2025 (June 30)17holders +1
4new positions
3sold out
$2.32avg. 13F price*
At the end of Q2 2025, 17 institutions reported holding Biomarin Pharmaceutical (bmrn 1.25 05/15/27) in their 13F filings, up 1 from Q1 2025. 4 opened new positions and 3 sold out. The largest holders were Loomis Sayles & Co. L P ($13.9M), Sonora Investment Management Group, LLC ($3.4M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.7M).
- Company
- Biomarin Pharmaceutical (bmrn 1.25 05/15/27)
- CUSIP
- 09061GAK7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $2.0M |
| Exits | 3 | $43K |
All 13F filers, Q1 2025 → Q2 2025: 2,082,001 shares bought and 1,377,009 shares sold, net +704,992 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Loomis Sayles & Co. L P | 0.02% | Reduce -74.5% | 252,345 | $13.9M |
| Sonora Investment Management Group, LLC | 0.26% | Reduce -10.7% | 3,645,000 | $3.4M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Add +0.0% | 2,900,000 | $2.7M |
| State of Wisconsin Investment Board | 0.00% | New | 2,000,000 | $1.9M |
| Sei Investments Co. | 0.00% | Reduce -29.2% | 371,000 | $349K |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $281K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -1.1% | 178,000 | $168K |
| Stephens Inc. | 0.00% | Add +3.9% | 54,000 | $51K |
| Mariner, LLC | 0.00% | No change | 42,000 | $40K |
| Cerity Partners LLC | 0.00% | New | 34,000 | $32K |
| &partners | 0.00% | New | 30,000 | $28K |
| Choreo, LLC | 0.00% | Add +21.7% | 28,000 | $26K |
| HB Wealth Management, LLC | 0.00% | New | 11,000 | $10K |
| DAVENPORT & Co LLC | 0.00% | No change | 10,000 | $9K |
| Cetera Investment Advisers | 0.00% | No change | 10,000 | $9K |
| Comerica Bank | 0.00% | Reduce -40.0% | 9,000 | $8K |
| Oddo BHF Asset Management Sas | 0.00% | Reduce -47.1% | 225 | $213 |
"% of holder's portfolio" is BIOMARIN PHARMACEUTICAL (BMRN 1.25 05/15/27)'s weight in each manager's 13F, not the share of Biomarin Pharmaceutical (bmrn 1.25 05/15/27) the manager owns.